Literature DB >> 12930371

Defective function of Fas in T cells from paediatric patients with autoimmune thyroid diseases.

G Bona1, S Defranco, A Chiocchetti, M Indelicato, A Biava, D Difranco, I Dianzani, U Ramenghi, A Corrias, G Weber, V De Sanctis, L Iughetti, G Radetti, U Dianzani.   

Abstract

Triggering of the Fas receptor induces T cell apoptosis and is involved in shutting-off the immune response. Inherited defects impairing Fas function cause the autoimmune lymphoproliferative syndrome, and may play a role in other autoimmune diseases. The aim of this work was to analyse the Fas function in paediatric patients with thyroid autoimmunities. We found that T cells from 24/28 patients with Graves' disease (GD) and 12/35 patients with Hashimoto's thyroiditis (HT) displayed defective Fas function. In HT, the defect was more frequent in patients requiring replacement therapy (11/20) than in those not requiring (1/15); moreover, in untreated HT the highest defect was displayed by patients with the highest levels of autoantibodies. Fas was always expressed at normal levels and no Fas mutations were detected. Analysis of the healthy parents of seven Fas-resistant patients showed that several of them were Fas-resistant, which suggests a genetic component. Fusion of Fas-resistant T cells with the Fas-sensitive HUT78 T cell line generated Fas-resistant hybrid cells, which suggests the presence of molecules exerting a dominant negative effect on Fas function. Analysis of Fas-induced activation of caspase-8 and -9 showed decreased activity of both caspases in HT, whereas activity of caspase-9 was increased and that of caspase-8 was decreased in GD. These data suggest that heterogeneous inherited defects impairing Fas function favour the development of thyroid autoimmunities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930371      PMCID: PMC1808790          DOI: 10.1046/j.1365-2249.2003.02221.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  IL-15 and IL-2: a matter of life and death for T cells in vivo.

Authors:  X C Li; G Demirci; S Ferrari-Lacraz; C Groves; A Coyle; T R Malek; T B Strom
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

Review 2.  Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity.

Authors:  P Rovere; M G Sabbadini; F Fazzini; A Bondanza; V S Zimmermann; C Rugarli; A A Manfredi
Journal:  Arthritis Rheum       Date:  2000-08

3.  Frequent mutations of Fas gene in thyroid lymphoma.

Authors:  T Takakuwa; Z Dong; H Takayama; F Matsuzuka; S Nagata; K Aozasa
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

Review 4.  Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?

Authors:  J D Trudeau; J P Dutz; E Arany; D J Hill; W E Fieldus; D T Finegood
Journal:  Diabetes       Date:  2000-01       Impact factor: 9.461

5.  CD4+ T cell-mediated cytotoxicity toward thyrocytes: the importance of Fas/Fas ligand interaction inducing apoptosis of thyrocytes and the inhibitory effect of thyroid-stimulating hormone.

Authors:  A Kawakami; N Matsuoka; M Tsuboi; T Koji; S Urayama; N Sera; A Hida; T Usa; H Kimura; N Yokoyama; T Nakashima; N Ishikawa; K Ito; Y Kawabe; K Eguchi
Journal:  Lab Invest       Date:  2000-04       Impact factor: 5.662

6.  Expression of bcl-2, Bax and Fas in oxyphil cells of Hashimoto thyroiditis.

Authors:  J Müller-Höcker
Journal:  Virchows Arch       Date:  2000-06       Impact factor: 4.064

7.  Defective T cell fas function in patients with multiple sclerosis.

Authors:  C Comi; M Leone; S Bonissoni; S DeFranco; F Bottarel; C Mezzatesta; A Chiocchetti; F Perla; F Monaco; U Dianzani
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

8.  Increased serum soluble Fas in patients with Graves' disease.

Authors:  Y Hiromatsu; T Bednarczuk; E Soyejima; I Miyake; D Yang; H Fukazawa; K Nonaka
Journal:  Thyroid       Date:  1999-04       Impact factor: 6.568

9.  Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.

Authors:  U Ramenghi; S Bonissoni; G Migliaretti; S DeFranco; F Bottarel; C Gambaruto; D DiFranco; R Priori; F Conti; I Dianzani; G Valesini; F Merletti; U Dianzani
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

10.  Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases.

Authors:  S DeFranco; S Bonissoni; F Cerutti; G Bona; F Bottarel; F Cadario; A Brusco; G Loffredo; I Rabbone; A Corrias; C Pignata; U Ramenghi; U Dianzani
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

View more
  7 in total

1.  The prediction effects of thyroid function in the severity of Guillain-Barré syndrome.

Authors:  Lingxin Kong; Xiujuan Wu; Yanwei Cheng; Shan Liu; Kangding Liu; Chunrong Li
Journal:  Neurol Sci       Date:  2022-04-26       Impact factor: 3.830

2.  Immunological changes of T helper cells in flow cytometer-sorted CD4+ T cells from patients with Hashimoto's thyroiditis.

Authors:  Yanying Guo; Jazyra Zynat; Shuqing Xing; Liang Xin; Suli Li; Nurongguli Mammat; Yuan Chen; Limin Zhao; Hongli Zhao; Xinling Wang
Journal:  Exp Ther Med       Date:  2018-02-01       Impact factor: 2.447

Review 3.  Targeting apoptosis in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2014-07-20       Impact factor: 3.199

4.  Xenobiotic exposure and autoimmune hepatitis.

Authors:  Kathleen M Gilbert
Journal:  Hepat Res Treat       Date:  2010-12-30

5.  High Serum IgG4 Concentrations in Patients with Hashimoto's Thyroiditis.

Authors:  Anna Popławska-Kita; Maria Kościuszko-Zdrodowska; Katarzyna Siewko; Beata Telejko; Justyna Hryniewicka; Robert Milewski; Saeid Soleman Abdelrazek; Małgorzata Szelachowska; Maria Górska
Journal:  Int J Endocrinol       Date:  2015-02-16       Impact factor: 3.257

Review 6.  Immune disorders in Hashimoto's thyroiditis: what do we know so far?

Authors:  Aleksandra Pyzik; Ewelina Grywalska; Beata Matyjaszek-Matuszek; Jacek Roliński
Journal:  J Immunol Res       Date:  2015-04-27       Impact factor: 4.818

Review 7.  Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease.

Authors:  Tristan Struja; Alexander Kutz; Stefan Fischli; Christian Meier; Beat Mueller; Mike Recher; Philipp Schuetz
Journal:  BMC Med       Date:  2017-09-25       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.